Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma
✍ Scribed by A Avilés; J.C Díaz-Maqueo; A Talavera; E.L García; R Guzmán; M.J Nambo
- Book ID
- 117663866
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 326 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Autologous bone marrow transplantation (ABMT) following intensive therapy regimes is being used increasingly in relapsed lymphomas. To date no randomised studies have been performed to ascertain the value of this form of therapy. We describe here our experience of ABMT in both Hodgkin's disease and
## Abstract Between September 1987 and May 1991, 21 children aged 10 months to 15 years (median 9 years) underwent bone marrow transplantation (BMT) for advanced haematological malignancies using a conditioning regimen consisting of total body irradiation (TBI), etoposide 1.8 g/m^2^ by continuous i